Skip to main content
. 2018 Jul 30;15(8):1614. doi: 10.3390/ijerph15081614
Bisphenol A (BPA; 4,4′-(propane-2,2-diyl)diphenol)
OP 4-tert-Octylphenol
E2 17β-Estradiol
P4 Progesterone
ICI ICI 182,780
EDs Endocrine disrupting chemicals
TRPV5 and TRPV6 Transient receptor potential cation channel subfamily V (TRPV) member 5 and 6
PMCA1 Plasma membrane Ca2+-ATPase 1
NCX1 Na+/Ca2+ exchanger 1
LIF Leukemia inhibitory factor
HOXA-10 homebox gene member 10
MUC1 Mucin 1
ERα and ERβ Estrogen receptor alpha and beta
PR- and PR-B Progesterone receptor and progesterone receptor B
LOAEL Lowest-observed-adverse-effect level